{"id": "1243450908920463362", "creation": 1585296773.0, "user_id": "845811110", "social_network": "twitter", "nsfw": false, "request": ["1aac5aa9-16ef-4aef-93e1-0b43ea7d03cb"], "metrics": {"1aac5aa9-16ef-4aef-93e1-0b43ea7d03cb": {"retweet_count": 1, "reply_count": 0, "like_count": 0, "quote_count": 0}}, "text": "Top #COVID-19 aspirants #chloroquine, AbbVie's anti-HIV drug #Kaletra (aka lopinavir/ ritonavir) and a flu drug (#Arbidol aka umifenovir) disappoint in Chinese clinical trials. But more trials are ongoing. https://t.co/oFZ5BUKtP2 @FiercePharma", "first_save": 1635413522.816877, "hashtags": ["#COVID", "#CHLOROQUINE", "#KALETRA", "#ARBIDOL"]}